Skip to content

Public FDA record

Z-0224-2025: Quantum Perfusion Systems for CPB, Roller Pumps use peristaltic action to propel blood through the venous

Recall record Z-0224-2025 for Spectrum Medical Ltd.. View source facts, labeled dates, and the original FDA record.

FDA identifier
Z-0224-2025
Company in FDA record
Spectrum Medical Ltd.
FDA classification date
Oct 24, 2024
First observed by MedTech Watch
Nov 16, 2026
Latest observed content change
Nov 16, 2026
Recall classification
Class II

Reason stated in the source

The ratchet and pawl had an out of tolerance geometry which exhibited as the left bobbin would not lock.

Source facts

Action
All potentially affected product was identified. The firm corrected all products between 03/13/2024 and 08/07/2024 during service visits.
Initiated
2023-03-13
Root cause
Component design/selection
Distribution
US Nationwide distribution including in the states of Alabama, California, Florida, Kentucky, Maine, Massachusetts, Minnesota, Missouri, New Jersey, New York, North Carolina, Ohio, Oklahoma, Pennsylvania, Tennessee, Texas, Utah, West Virginia.
Recall number
Z-0224-2025
Recall status
Completed
CDRH record ID
210236
FDA classified
2024-10-24
Recall event number
95428

Source facts and excerpts are reproduced for research. Dates retain their source meanings. “First observed” describes collection, not FDA publication or product launch.

Recall classification is supplied only when the recall number matches an enforcement record. Recall class and device class are different fields. Several recall records may belong to one recall event.

Useful context

Device classifications

FDA dataset:

Last successful check: Nov 22, 2026

Source classifications may change.

510(k) clearances

FDA dataset:

Last successful check: Nov 22, 2026

FDA publishes this dataset monthly.

Recall records

FDA dataset:

Last successful check: Nov 22, 2026

FDA publishes this dataset weekly.

Keep this research moving.

Follow ten competitors and ten product codes. Get matching changes in your dashboard and a weekly brief, for $49/month.

Start a 14-day free trial ↗